Comprehensive cloning of patient-derived 9022-bp amplicons of hepatitis C virus

Journal of Virological Methods

Volumn 191, Issue 2, 2013, Pages 105-112

  Lu, Yang ^a,c   Xu, Yanjuan ^a   Di Bisceglie, Adrian M ^a,b   Fan, Xiaofeng ^a,b  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Saint Louis University   (United States)

^c Department of Internal Medicine   (China)

Author keywords

Cloning; Hepatitis C virus; Long RT PCR

Indexed keywords

AMPLICON; ARTICLE; CELL CULTURE; CONTROLLED STUDY; ESCHERICHIA COLI; GENOMIC INSTABILITY; HEPATITIS C VIRUS; HUMAN; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENY; PREDICTIVE VALUE; PRIORITY JOURNAL; PROMOTER REGION; REVERSE GENETICS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS GENOME; VIRUS STRAIN;

CLONING, MOLECULAR; ESCHERICHIA COLI; GENETIC VECTORS; GENOMIC INSTABILITY; HEPACIVIRUS; HEPATITIS C; HUMANS; PLASMIDS; PROMOTER REGIONS, GENETIC; VIROLOGY;

EID: 84877883253     PISSN: 01660934     EISSN: 18790984     Source Type: Journal    
DOI: 10.1016/j.jviromet.2013.04.010     Document Type: Article

References (36)

1. Alter M.J., Kruszon-Moran D., Nainan O.V., McQuillan G.M., Gao F., Moyer L.A., Kaslow R.A., Margolis H.S. Prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N. Engl. J. Med. 1999, 341:556-562.
2. Aslanidis C., de Jong P.J. Ligation-independent cloning of PCR products (LIC-PCR). Nucleic Acids Res. 1990, 18:6069-6074.
3. Broadbent S., van der Woude M., Aziz N. Accurate and simple sizing of primer extension products using a non-radioactive approach facilitates identification of transcription initiation sites. J. Microbiol. Methods 2010, 81:256-258.
4. Brown W.C., Campbell J.L. A new cloning vector and expression strategy for genes encoding proteins toxic to Escherichia coli. Gene 1993, 127:99-103.
5. Chambers T.J., Fan X., Droll D.A., Hembrador E., Slater T., Nickells M.W., Dustin L.B., Di Bisceglie A.M. E1/E2 quaispecies heterogeneity as a pretreatment variable during pegylated interferon therapy of chronic HCV infection. J. Virol. 2005, 79:3071-3083.
6. Choo Q.L., Kuo G., Weiner A.J., Overby L.R., Bradley D.W., Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989, 244:359-362.
7. Cirino P.C., Mayer K.M., Umeno D. Generating mutant libraries using error-prone PCR. Methods Mol. Biol. 2003, 231:3-9.
8. Domingo E., Martin V., Perales C., Grande-Perez A., Garcia-Arriaza J., Arias A. Viruses as quasispecies: biological implications. Curr. Top. Microbiol. Immunol. 2006, 299:51-82.
9. Fan X., Mao Q., Zhou D., Xing J., Xu Y., Ray S.C., Di Bisceglie A.M. High diversity of hepatitis C viral quasispecies is associated with early virological response in patients undergoing antiviral therapy. Hepatology 2009, 50:1765-1772.
10. Fan X., Xu Y., Di Bisceglie A.M. Efficient amplification and cloning of near full-length hepatitis C virus genome from clinical samples. Biochem. Biophys. Res. Commun. 2006, 346:1163-1172.
11. Farci P., Shimoda A., Coiana A., Diaz G., Peddis G., Melpolder J.C., Strazzera A., Chien D.Y., Munoz S.J., Balestrieri A., Purcell R.H., Alter H.J. The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies. Science 2000, 288:339-344.
12. Frey U.H., Bachmann H.S., Peters J., Siffert W. PCR-amplification of GC-rich regions: 'slowdown PCR'. Nat. Protoc. 2008, 3:1312-1317.
13. Grime S.K., Martin R.L., Holaway B.L. Inhibition of restriction enzyme cleavage of DNA modified with 7-deaza-dGTP. Nucleic Acids Res. 1991, 19:2791.
14. Jung A., Ruckert S., Frank P., Brabletz T., Kirchner T. 7-Deaza-2'-deoxyguanosine allows PCR and sequencing reactions from CpG islands. Mol. Pathol. 2002, 55:55-57.
15. Kuiken C., Yusim K., Boykin L., Richardson R. The Los Alamos HCV sequence database. Bioinformatics 2005, 21:379-384.
16. Li D., Aaskov J., Lott W.B. Identification of a cryptic prokaryotic promoter within the cDNA encoding the 5' end of dengue virus RNA genome. PLoS One 2011, 6:e18197.
17. Manen D., Goebel T., Caro L. The par region of pSC101 affects plasmid copy number as well as stability. Mol. Microbiol. 1990, 4:1839-1846.
18. Nohno T., Kasai Y., Saito T. Cloning and sequencing of the Escherichia coli chlEN operon involved in molybdopterin biosynthesis. J. Bacteriol. 1988, 170:4097-4102.
19. Nohno T., Saito T., Hong J.S. Cloning and complete nucleotide sequence of the Escherichia coli glutamine permease operon (glnHPQ). Mol. Gen. Genet. 1986, 205:260-269.
20. Orosz A., Boros I., Venetianer P. Analysis of the complex transcription termination region of the Escherichia coli rrnB gene. Eur. J. Biochem. 1991, 201:653-659.
21. Pickett B.E., Striker R., Lefkowitz E.J. Evidence for separation of HCV subtype 1a into two distinct clades. J. Viral Hepatol. 2011, 18:608-618.
22. Pu S.Y., Wu R.H., Yang C.C., Jao T.M., Tsai M.H., Wang J.C., Lin H.M., Chao Y.S., Yueh A. Successful propagation of flavivirus infectious cDNAs by a novel method to reduce the cryptic bacterial promoter activity of virus genomes. J. Virol. 2011, 85:2927-2941.
23. Reese M.G. Application of a time-delay neural network to promoter annotation in the Drosophila melanogaster genome. Comput. Chem. 2001, 26:51-56.
24. Ruggli N., Rice C.M. Functional cDNA clones of the Flaviviridae: strategies and applications. Adv. Virus Res. 1999, 53:183-207.
25. She K. So you want to work with giants: The BAC vector. BioTeach J. 2003, 1:69-74.
26. Studier F.W. Protein production by auto-induction in high density shaking cultures. Protein Exp. Purif. 2005, 41:207-234.
27. Tamura K., Peterson D., Peterson N., Stecher G., Nei M., Kumar S. MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol. Biol. Evol. 2011, 28:2731-2739.
28. Tellinghuisen T.L., Evans M.J., von Hahn T., You S., Rice C.M. Studying hepatitis C virus: making the best of a bad virus. J. Virol. 2007, 81:8853-8867.
29. Wakita T., Pietschmann T., Kato T., Date T., Miyamoto M., Zhao Z., Murthy K., Habermann A., Krausslich H.G., Mizokami M., Bartenschlager R., Liang T.J. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat. Med. 2005, 11:791-796.
30. Weiss J., Zucht H.D., Forssmann W.G. Amplification of gene fragments with very high G/C content: c7dGTP and the problem of visualizing the amplification products. PCR Methods Appl. 1994, 4:124-125.
31. Wild J., Hradecna Z., Szybalski W. Conditionally amplifiable BACs: switching from single-copy to high-copy vectors and genomic clones. Genome Res. 2002, 12:1434-1444.
32. Xu Z., Fan X., Xu Y., Di Bisceglie A.M. Comparative analysis of near full-length hepatitis C viral quasispecies in patients experiencing viral breakthrough during antiviral therapy. J. Virol. 2008, 82:9417-9424.
33. Yamshchikov V., Mishin V., Cominelli F. A new strategy in design of +RNA virus infectious clones enabling their stable propagation in E. coli. Virology 2001, 281:272-280.
34. Zhang Y., Taiming L., Liu J. Low temperature and glucose enhanced T7 RNA polymerase-based plasmid stability for increasing expression of glucagon-like peptide-2 in Escherichia coli. Protein Exp. Purif. 2003, 29:132-139.
35. Zhong J., Gastaminza P., Cheng G., Kapadia S., Kato T., Burton D.R., Wieland S.F., Uprichard S.L., Wakita T., Chisari F.V. Robust hepatitis C virus infection in vitro. Proc. Nat. Acad. Sci. U S A 2005, 102:9294-9299.
36. Zhou D., Fan X., Tan D., Xu Y., Tavis J.E., Di Bisceglie A.M. Separation of near full-length hepatitis C virus quasispecies variants from a complex population. J. Virol. Methods 2007, 141:220-224.